Navigation Links
Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors

HAYWARD, Calif., June 5, 2013 /PRNewswire/ -- Rafael Simon, a veteran in the environment and energy industries, has joined Microvi Biotechnologies as Chairman of its Board of Directors. Rafael was the COO of Zenon Environmental, a leading water treatment company, previous to its acquisition by GE Water in 2006 for nearly $700 M.

(Photo: )

While at Zenon, Rafael was responsible for all aspects of sales, operations, R&D and manufacturing. During his tenure at Zenon, share price tripled and he was named Canada's top COO by Canadian Business, Canada's leading business magazine.

"Rafael brings expertise in strategy and a depth of knowledge in our market focus that will be important in Microvi's continuing commercialization of its MicroNiche Engineering Platform Technology," said Dr. Fatemeh Shirazi , CEO of Microvi. "I am delighted to welcome him as Chairman of Microvi's Board of Directors."

He joins Microvi at a pivotal growth period, building on successful scaling and commercialization of the company's platform technology and various biocatalytic solutions for clean water, renewable biofuels, biochemicals and other industrial bioprocesses.

"I'm excited to have the opportunity to help scale-up the revolutionary Microvi biocatalyst technology which has the potential to disrupt so many industries," said Rafael.

Previous to his work with Zenon, Rafael worked at McKinsey & Company specializing in corporate growth strategies for water and energy companies.  Rafael currently serves as director on a number of boards internationally and received his Ph.D. in Materials Science and Mineral Engineering from the University of California, Berkeley.

About Microvi

Microvi is a leading biotechnology company that discovers, develops, manufactures, and commercializes innovative biocatalytic technologies in water, energy and chemical industries. Microvi's pipeline of solutions, created using its proprietary MicroNiche Engineering™ platform, enable cost-effective economics, are energy efficient and waste free and deliver higher performance than conventional methods. To learn more please visit

Media Contact:

Karin Kidder , Microvi Biotechnologies, 1-510-344-0668

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Microvi
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
2. Dr. Gerald Jerry Zon Launches New Blog for TriLink BioTechnologies
3. TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark
4. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
5. TriLink BioTechnologies Awards Keck Science Department ResearchReward
6. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
7. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
8. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
9. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
10. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
11. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT ... provide a corporate overview. th Annual Oppenheimer Healthcare ... ET/10:00 a.m. PT . Jim Mazzola , vice president ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... event of the year and one of the premier annual events for pharmaceutical ... ran from 8–11 November 2015, where ISPE hosted the largest number of attendees ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
Breaking Biology Technology:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/9/2015)... JOSE, Calif. , Nov. 9, 2015  Synaptics ... human interface solutions, today announced broader entry into the ... vehicle-specific solutions that match the pace of consumer electronics ... and biometric sensors are ideal for the automotive industry ... vehicle. Europe , ...
Breaking Biology News(10 mins):